These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 11073768)

  • 1. Decline in antibiotic enzyme activity of neutrophils is a prognostic factor for infections in patients with myelodysplastic syndrome.
    Ito Y; Kawanishi Y; Shoji N; Ohyashiki K
    Clin Infect Dis; 2000 Nov; 31(5):1292-5. PubMed ID: 11073768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased intracellular activity of matrix metalloproteinases in neutrophils may be associated with delayed healing of infection without neutropenia in myelodysplastic syndromes.
    Yamaguchi N; Ito Y; Ohyashiki K
    Ann Hematol; 2005 Jun; 84(6):383-8. PubMed ID: 15711801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma vascular endothelial growth factor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromes.
    Aguayo A; Kantarjian HM; Estey EH; Giles FJ; Verstovsek S; Manshouri T; Gidel C; O'Brien S; Keating MJ; Albitar M
    Cancer; 2002 Nov; 95(9):1923-30. PubMed ID: 12404286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomerase activity in myelodysplastic syndromes.
    Gürkan E; Tanriverdi K; Başlamişli F
    Leuk Res; 2005 Oct; 29(10):1131-9. PubMed ID: 16111531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study on the Characteristics of cell cycle and proliferation of CD34+ hematopoietic stem cells in myelodysplastic syndromes].
    Shi J; Shao ZH; Liu H; Jia HR; Sun J; Bai J; Wu YH; Jing LP; He GS; Cao YR; Wang XL; Tu MF; Hao YS; Yang TY
    Zhonghua Xue Ye Xue Za Zhi; 2004 Nov; 25(11):641-4. PubMed ID: 15634564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss-of-function mutations in cathepsin C in two families with Papillon-Lefèvre syndrome are associated with deficiency of serine proteinases in PMNs.
    de Haar SF; Jansen DC; Schoenmaker T; De Vree H; Everts V; Beertsen W
    Hum Mutat; 2004 May; 23(5):524. PubMed ID: 15108292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological and clinical relevance of matrix metalloproteinases 2 and 9 in acute myeloid leukaemias and myelodysplastic syndromes.
    Travaglino E; Benatti C; Malcovati L; Della Porta MG; Gallì A; Bonetti E; Rosti V; Cazzola M; Invernizzi R
    Eur J Haematol; 2008 Mar; 80(3):216-26. PubMed ID: 18081721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human leukocyte elastase and cathepsin G are specific inhibitors of C5a-dependent neutrophil enzyme release and chemotaxis.
    Tralau T; Meyer-Hoffert U; Schröder JM; Wiedow O
    Exp Dermatol; 2004 May; 13(5):316-25. PubMed ID: 15140022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The elastolytic activity of cathepsin G: an ex vivo study with dermal elastin.
    Boudier C; Godeau G; Hornebeck W; Robert L; Bieth JG
    Am J Respir Cell Mol Biol; 1991 Jun; 4(6):497-503. PubMed ID: 1711351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Release and degradation of angiotensin I and angiotensin II from angiotensinogen by neutrophil serine proteinases.
    Ramaha A; Patston PA
    Arch Biochem Biophys; 2002 Jan; 397(1):77-83. PubMed ID: 11747312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and toxicity of low-dose melphalan in myelodysplastic syndromes and acute myeloid leukemia with multilineage dysplasia.
    Robak T; Szmigielska-Kapłon A; Urbańska-Ryś H; Chojnowski K; Wrzesień-Kuś A
    Neoplasma; 2003; 50(3):172-5. PubMed ID: 12937849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphism analysis of CYP3A5 in myeloid leukemia.
    Liu TC; Lin SF; Chen TP; Chang JG
    Oncol Rep; 2002; 9(2):327-9. PubMed ID: 11836601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accelerated cellular senescence in myelodysplastic syndrome.
    Wang YY; Cen JN; He J; Shen HJ; Liu DD; Yao L; Qi XF; Chen ZX
    Exp Hematol; 2009 Nov; 37(11):1310-7. PubMed ID: 19748549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levels of beta 2 microglobulin have a prognostic relevance for patients with myelodysplastic syndrome with regard to survival and the risk of transformation into acute myelogenous leukemia.
    Neumann F; Gattermann N; Barthelmes HU; Haas R; Germing U
    Leuk Res; 2009 Feb; 33(2):232-6. PubMed ID: 18639338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SHP1 expression in bone marrow biopsies of myelodysplastic syndrome patients: a new prognostic factor.
    Mena-Duran AV; Togo SH; Bazhenova L; Cervera J; Bethel K; Senent ML; Nieva J; Sanz GF; Sanz MA; Saven A; Mustelin T
    Br J Haematol; 2005 Jun; 129(6):791-4. PubMed ID: 15953006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
    Orazi A
    Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiating agents + low-dose chemotherapy in the management of old/poor prognosis patients with acute myeloid leukemia or myelodysplastic syndrome.
    Ferrero D; Campa E; Dellacasa C; Campana S; Foli C; Boccadoro M
    Haematologica; 2004 May; 89(5):619-20. PubMed ID: 15136232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biosynthetic profiles of neutrophil serine proteases in a human bone marrow-derived cellular myeloid differentiation model.
    Garwicz D; Lennartsson A; Jacobsen SE; Gullberg U; Lindmark A
    Haematologica; 2005 Jan; 90(1):38-44. PubMed ID: 15642667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of E. faecalis on the release of serine proteases elastase and cathepsin G, and collagenase-2 (MMP-8) by human polymorphonuclear leukocytes (PMNs).
    Reynaud af Geijersstam A; Sorsa T; Stackelberg S; Tervahartiala T; Haapasalo M
    Int Endod J; 2005 Sep; 38(9):667-77. PubMed ID: 16104981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What does apoptosis have to do with clinical features in myelodysplastic syndrome?
    Ramos F; Fuertes-Núñez M; Suárez-Vilela D; Fernández-López A
    Haematologica; 2002 Apr; 87(4):381-91. PubMed ID: 11940482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.